The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
- Valuing and accessing medicines
- RESEARCH, DEVELOPMENT AND MANUFACTURING
- WORKING IN PARTNERSHIP
- Industry Reputation
- International Policy, Trade & IP
- Health Data
Valuing and accessing medicines
Ensuring value, access and uptake of innovative medicines and vaccines, now and in the future
Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. The pharmaceutical industry spends $160 billion per year on research and development.The private sector produces nearly all the medicines and vaccines available to us. Companies need to make a profit – and a return – on global investment in order to maintain investment in the next generation of medicines.
RESEARCH, DEVELOPMENT AND MANUFACTURING
Improving the UK's attractiveness for industry, research, development and manufacturing
We're helping to build a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines.
WORKING IN PARTNERSHIP
Building better partnerships between industry and NHS and across the Life Sciences sector
We have a long-standing positive relationship with the NHS, and a record of facilitate the same across various parties across the Life Sciences sector. We believe in focusing collaboration on where it can add the most value in making innovation as widely available to patients as possible.
Industry Reputation
Building a stronger industry reputation in the UK
Everywhere, every day someone relies on the results of our work to ensure their health and wellbeing. We are proud of this and are committed to working with a wide range of people - patients, doctors, nurses, regulators and governments - in order to deliver medicines in an ethically responsible way. Patients are at the heart of everything that we do.
International Policy, Trade & IP
Providing international leadership and driving global policy
The ABPI is working to ensure that the UK has the best relationship with our international partners for patients, public health and the life sciences sector.
Health Data
Improving the UK's health data capability and industry's access to data
We aim to harness the UK’s health data to support the efficient design, feasibility, recruitment and conduct of the full range of clinical trials. We are helping the UK make the most of health-related data for future research and development into new medicines.
Supporting the era of green pharmaceuticals in the UK
To overcome the challenges and accelerate progress on carbon reduction and other sustainability goals, the pharmaceutical industry needs to engage in partnerships with the NHS and UK government, in addition to the need for more cross-industry collaboration. There are a number of high-priority activities that the NHS, UK government and industry should undertake to tackle these challenges.
Read this OHE reportSustainability in the pharmaceutical industry
Read cases studies about sustainability in the pharmaceutical industry
Latest news
ABPI responds to Bioscience and health technology sector statistics 2021
The Office for Life Sciences today published economic data on Bioscience and health technology sector statistics 2021, which show stable levels of sector employment, and sharp growth in sector turnover.
ABPI response to Board of Trade report on Life Sciences
ABPI response to the UK Board of Trade’s latest report on the UK life sciences
Developing new antibiotics key for the race against resistant infections, says ABPI
World Antimicrobial Awareness Week aims to improve the awareness and understanding of antimicrobial resistance (AMR).
ABPI response to the Autumn Statement
The Association of the British Pharmaceutical Industry (ABPI) has welcomed Chancellor Jeremy Hunt’s Autumn Statement for recognising the vital role UK life sciences will play in delivering innovation-led growth.
Latest blogs and events
By coming together, we can overcome antimicrobial resistance
Reflections on World Antimicrobial Awareness Week 2022 from Dr Amit Aggarwal, ABPI Executive Director, Medical Affairs.
Reflections from NICON22
Commentary on this year's Northern Ireland Annual Conference and Exhibition 2022.
Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?
A new analysis commissioned by the ABPI suggests they could.
The Innovative Medicines Fund - Good news for patients but has an opportunity been missed to be more ambitious?
NHS England and Improvement (NHSE/I) has announced the launch of the Innovative Medicines Fund. The ABPI’s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the announcement.
Key content hubs
This covers the latest research from the ABPI-Ipsos attitudes towards pharmaceutical companies in the UK study.
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
The International Clinical Researcher of the Year Clinical Site Team Award is back for 2023 sponsored by the NIHR and @ABPI_UK 🏆
— NIHR for Industry (@NIHR_Industry) December 1, 2022
Entries are invited from highly motivated teams, committed to excellence.
Do you know a team like that?
Share the link: https://t.co/6BjloZzV2z pic.twitter.com/LFxCEJCf0D
Read our response to economic data on Bioscience and health technology sector statistics 2021, published today: https://t.co/zk3Y3AP4Yj@beisgovuk @UK_Life_Science @DHSCgovuk
— ABPI (@ABPI_UK) December 1, 2022
UKG minister for Scotland @john2win attended the launch of the Medicines Manufacturing Innovation Centre, a state-of-the-art facility led by @ukCPI to develop & commercialise technologies that improve medicines manufacturing. #ConnectingPharma #LetsInnovateTogether #CPIPharma pic.twitter.com/qryxfNNdsW
— Office of the Secretary of State for Scotland (@ScotSecofState) November 30, 2022
Great to see the MMIC launched and look forward to it boosting UK innovation 🔽 https://t.co/lodu3r5z7J
— ABPI (@ABPI_UK) November 30, 2022
The Pharmaceutical Industry in the UK
![R and D Investment [3]](/media/ouqnhlry/figures-r-d-investment-5-0bn.jpg)
Members
Online members portal (ABPI Meetings via Adam.ai)
ABPI members can log in for bespoke content and services.